The European Commission has launched a call, COVID19 – HERA Incubator (HORIZON-HLTH-2021-CORONA-01), that will mobilize all means and resources necessary to prevent, mitigate and respond to the potential impact of COVID-19 variants.
This specific call aims at supporting activities that enable the conduct of vaccine & therapeutic trials to boost prevention and further inform public health policy and clinical management. Proposals submitted under this expression of interest should aim to further develop promising therapeutic or prophylactic candidates against SARS-CoV-2/COVID-19
Asphalion is actively involved in several European granted H2020 projects consortium as partner, taking care of the regulatory activities during the development of different innovative products. Furthermore, Asphalion is already participating as a Regulatory Partner in different COVID-19 related projects.
In case you need further information please contact us at: h2020@asphalion.com
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...
